{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:23:20Z","timestamp":1777627400078,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["DS 48"],"award-info":[{"award-number":["DS 48"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Unsatisfactory therapeutic effects of currently used antidepressants force to search for new pharmacological treatment strategies. Recent research points to the relationship between depressive disorders and the adenosinergic system. Therefore, the main goal of our studies was to evaluate the effects of DMPX (3\u00a0mg\/kg, i.p.), which possesses selectivity for adenosine A<jats:sub>2A<\/jats:sub>receptors versus\u00a0A<jats:sub>1<\/jats:sub>receptors, on the activity of imipramine (15\u00a0mg\/kg, i.p.), escitalopram (2.5\u00a0mg\/kg, i.p.), and reboxetine (2\u00a0mg\/kg, i.p.) given in subtherapeutic doses. The studies carried out using the\u00a0forced swim and tail suspension tests in mice showed that DMPX at a dose of 6 and 12\u00a0mg\/kg exerts antidepressant-like effect and does not affect the locomotor activity. Co-administration of DMPX at a dose of 3\u00a0mg\/kg with the studied antidepressant drugs caused the reduction of immobility time in both behavioral tests. The observed effect was not associated with an increase in the locomotor activity. To evaluate whether the observed effects were due to a pharmacokinetic\/pharmacodynamic interaction, the levels of the antidepressants in blood and brain were measured using high-performance liquid chromatography. It can be assumed that the interaction between DMPX and imipramine was exclusively pharmacodynamic in nature, whereas an increased antidepressant activity of escitalopram and reboxetine was at least partly related to its pharmacokinetic interaction with DMPX.<\/jats:p>","DOI":"10.1007\/s12640-018-9959-2","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T01:40:02Z","timestamp":1538098802000},"page":"344-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist"],"prefix":"10.1007","volume":"35","author":[{"given":"Ewa","family":"Poleszak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2904","authenticated-orcid":false,"given":"Aleksandra","family":"Szopa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Bogatko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Wo\u015bko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"\u015awi\u0105der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"9959_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1126\/science.182.4107.20","volume":"182","author":"HS Akiskal","year":"1973","unstructured":"Akiskal HS, McKinney WT (1973) Depressive disorders: toward a unified hypothesis. Science 182:20\u201329","journal-title":"Science"},{"key":"9959_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.04.017","volume":"70","author":"T Ali-Sisto","year":"2016","unstructured":"Ali-Sisto T, Tolmunen T, Toffol E, Viinamaki H, Mantyselka P, Valkonen-Korhonen M, Honkalampi K, Ruusunen A, Velagapudi V, Lehto SM (2016) Purine metabolism is dysregulated in patients with major depressive disorder. Psychoneuroendocrinology 70:25\u201332","journal-title":"Psychoneuroendocrinology"},{"key":"9959_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.pharmthera.2011.07.004","volume":"132","author":"MT Armentero","year":"2011","unstructured":"Armentero MT, Pinna A, Ferr\u00e9 S, Lanciego JL, M\u00fcller CE, Franco R (2011) Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson\u2019s disease. Pharmacol Ther 132:280\u2013299","journal-title":"Pharmacol Ther"},{"key":"9959_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0924-977X(01)00074-8","volume":"11","author":"M Berk","year":"2001","unstructured":"Berk M, Plein H, Ferreira D, Jersky B (2001) Blunted adenosine A2a receptor function in platelets in patients with major depression. Eur Neuropsychopharmacol 11:183\u2013186","journal-title":"Eur Neuropsychopharmacol"},{"key":"9959_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0736-5748(98)00019-7","volume":"16","author":"G Biagini","year":"1998","unstructured":"Biagini G, Pich EM, Carani C, Marrama P, Agnati LF (1998) Postnatal maternal separation during the stress hyporesponsive period enhances the adrenocortical response to novelty in adult rats by affecting feedback regulation in the CA1 hippocampal field. Int J Dev Neurosc 16:187\u2013197","journal-title":"Int J Dev Neurosc"},{"key":"9959_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-642-18500-7_3","volume-title":"Antidepressants: past, present and future","author":"MJ Burke","year":"2004","unstructured":"Burke MJ, Preskorn SH (2004) Therapeutic drug monitoring of antidepressants. In: Preskorn SH, Feigher JP, Stanga CY, Ross R (eds) Antidepressants: past, present and future. Springer-Verlag, Heidelberg, pp 87\u2013117"},{"key":"9959_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2165\/00003088-199834040-00002","volume":"34","author":"S Caccia","year":"1998","unstructured":"Caccia S (1998) Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Clin Pharmacokinet 34:281\u2013302","journal-title":"Clin Pharmacokinet"},{"key":"9959_CR8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S0002-9378(99)70628-9","volume":"180","author":"A Chau","year":"1999","unstructured":"Chau A, Rose JC, Koos BJ (1999) Adenosine modulates corticotropin and cortisol release during hypoxia in fetal sheep. Am J Obstet Gynecol 180:1272\u20131277","journal-title":"Am J Obstet Gynecol"},{"key":"9959_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fpsyt.2014.00067","volume":"5","author":"JE Coelho","year":"2014","unstructured":"Coelho JE, Alves P, Canas PM, Valadas JS, Shmidt T, Batalha VL, Ferreira DG, Ribeiro JA, Bader M, Cunha RA, do Couto FS, Lopes LV (2014) Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety. Front Psychiatry 5:67","journal-title":"Front Psychiatry"},{"key":"9959_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35037600","volume":"407","author":"V Corset","year":"2000","unstructured":"Corset V, Nguyen-Ba-Charvet KT, Forcet C, Moyse E, Ch\u00e9dotal A, Mehlen P (2000) Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor. Nature 407:747\u2013750","journal-title":"Nature"},{"key":"9959_CR11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.neuroscience.2006.05.024","volume":"141","author":"GM Cunha","year":"2006","unstructured":"Cunha GM, Canas PM, Oliveira CR, Cunha RA (2006) Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141:1775\u20131781","journal-title":"Neuroscience"},{"key":"9959_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuint.2007.06.026","volume":"52","author":"RA Cunha","year":"2008","unstructured":"Cunha RA (2008) Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochem Int 52:65\u201372","journal-title":"Neurochem Int"},{"key":"9959_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2174\/138161208784480090","volume":"14","author":"RA Cunha","year":"2008","unstructured":"Cunha RA, Ferr\u00e9 S, Vaugeois JM, Chen JF (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 14:1512\u20131524","journal-title":"Curr Pharm Des"},{"key":"9959_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0165-6147(89)90203-4","volume":"10","author":"J Deckert","year":"1989","unstructured":"Deckert J, Gleiter CH (1989) Adenosinergic psychopharmaceuticals? Trends Pharmacol Sci 10:99\u2013100","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 6","key":"9959_CR15","first-page":"7","volume":"61","author":"PL Delgado","year":"2000","unstructured":"Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatry 61(Suppl 6):7\u201311","journal-title":"J Clin Psychiatry"},{"key":"9959_CR16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","volume":"118","author":"AK Dixon","year":"1996","unstructured":"Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461\u20131468","journal-title":"Br J Pharmacol"},{"key":"9959_CR17","doi-asserted-by":"crossref","unstructured":"Duman CH (2010) Models of depression. Vitam Horm 82:1\u201321","DOI":"10.1016\/S0083-6729(10)82001-1"},{"key":"9959_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0006-8993(83)91045-4","volume":"267","author":"C Ebersolt","year":"1983","unstructured":"Ebersolt C, Premont J, Prochiantz A, Perez M, Bockaert J (1983) Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations. Brain Res 267:123\u2013129","journal-title":"Brain Res"},{"key":"9959_CR19","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1212\/01.WNL.0000095220.87550.F6","volume":"61","author":"M El Yacoubi","year":"2003","unstructured":"El Yacoubi M, Costentin J, Vaugeois JM (2003) Adenosine A2A receptors and depression. Neurology 61:S82\u2013S87","journal-title":"Neurology"},{"key":"9959_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.bjp.0704240","volume":"134","author":"M El Yacoubi","year":"2001","unstructured":"El Yacoubi M, Ledent C, Parmentier M, Bertorelli R, Ongini E, Costentin J, Vaugeois JM (2001) Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol 134:68\u201377","journal-title":"Br J Pharmacol"},{"key":"9959_CR21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","volume":"20","author":"S Ferr\u00e9","year":"1997","unstructured":"Ferr\u00e9 S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482\u2013487","journal-title":"Trends Neurosci"},{"key":"9959_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0006-8993(92)91036-E","volume":"594","author":"S Ferr\u00e9","year":"1992","unstructured":"Ferr\u00e9 S, Fuxe K (1992) Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum. Brain Res 594:124\u2013130","journal-title":"Brain Res"},{"key":"9959_CR23","doi-asserted-by":"crossref","unstructured":"Ferr\u00e9 S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501\u2013512","DOI":"10.1016\/0306-4522(92)90291-9"},{"key":"9959_CR24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1460-9568.1996.tb01617.x","volume":"8","author":"S Ferr\u00e9","year":"1996","unstructured":"Ferr\u00e9 S, O'Connor WT, Svenningsson P, Bjorklund L, Lindberg J, Tinner B, Stromberg I, Goldstein M, Ogren SO, Ungerstedt U, Fredholm BB, Fuxe K (1996a) Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 8:1545\u20131553","journal-title":"Eur J Neurosci"},{"key":"9959_CR25","doi-asserted-by":"crossref","unstructured":"Ferr\u00e9 S, Popoli P, Tinner-Staines B, Fuxe K (1996b) Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites. Neurosci Lett 19:109\u2013112","DOI":"10.1016\/0304-3940(96)12577-5"},{"key":"9959_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0169-328X(92)90173-9","volume":"14","author":"JS Fink","year":"1992","unstructured":"Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 14:186\u2013195","journal-title":"Brain Res Mol Brain Res"},{"key":"9959_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.yexcr.2010.02.004","volume":"316","author":"BB Fredholm","year":"2010","unstructured":"Fredholm BB (2010) Adenosine receptors as drug targets. Exp Cell Res 316:1284\u20131288","journal-title":"Exp Cell Res"},{"key":"9959_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s002100000313","volume":"362","author":"BB Fredholm","year":"2000","unstructured":"Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W (2000) Structure and function of adenosine receptors and their genes. Naunyn Schmiedeberg's Arch Pharmacol 362:364\u2013374","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"9959_CR29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83\u2013133","journal-title":"Pharmacol Rev"},{"key":"9959_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","volume":"63","author":"BB Fredholm","year":"2005","unstructured":"Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM (2005a) Adenosine and brain function. Int Rev Neurobiol 63:191\u2013270","journal-title":"Int Rev Neurobiol"},{"key":"9959_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.pharmtox.45.120403.095731","volume":"45","author":"BB Fredholm","year":"2005","unstructured":"Fredholm BB, Chen JF, Masino SA, Vaugeois JM (2005b) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 45:385\u2013412","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9959_CR32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"key":"9959_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","volume":"151","author":"PK Gillman","year":"2007","unstructured":"Gillman PK (2007) Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 151:737\u2013748","journal-title":"Br J Pharmacol"},{"key":"9959_CR34","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","volume":"1808","author":"CV Gomes","year":"2011","unstructured":"Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808:1380\u20131399","journal-title":"Biochim Biophys Acta"},{"key":"9959_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1021\/tx700079z","volume":"21","author":"FP Guengerich","year":"2008","unstructured":"Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21:70\u201383","journal-title":"Chem Res Toxicol"},{"key":"9959_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.pnpbp.2010.06.013","volume":"35","author":"K Hashimoto","year":"2011","unstructured":"Hashimoto K (2011) The role of glutamate on the action of antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatry 35:1558\u20131568","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9959_CR37","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1073\/pnas.92.10.4666","volume":"92","author":"C Heurteaux","year":"1995","unstructured":"Heurteaux C, Lauritzen I, Widmann C, Lazdunski M (1995) Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 92:4666\u20134670","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9959_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1037\/0735-7044.117.1.123","volume":"117","author":"AM Hunter","year":"2003","unstructured":"Hunter AM, Balleine BW, Minor TR (2003) Helplessness and escape performance: glutamate-adenosine interactions in the frontal cortex. Behav Neurosci 117:123\u2013135","journal-title":"Behav Neurosci"},{"key":"9959_CR39","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1212\/01.WNL.0000095209.59347.79","volume":"61","author":"P Jenner","year":"2003","unstructured":"Jenner P (2003) A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD. Neurology 61:S32\u2013S38","journal-title":"Neurology"},{"key":"9959_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.parkreldis.2008.12.006","volume":"15","author":"P Jenner","year":"2009","unstructured":"Jenner P, Mori A, Hauser R, Morelli M, Fredholm BB, Chen JF (2009) Adenosine, adenosine A2A antagonists, and Parkinson\u2019s disease. Parkinsonism Relat Disord 15:406\u2013413","journal-title":"Parkinsonism Relat Disord"},{"key":"9959_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.pbb.2014.06.005","volume":"124","author":"PP Kale","year":"2014","unstructured":"Kale PP, Addepalli V (2014) Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice. Pharmacol Biochem Behav 124:238\u2013244","journal-title":"Pharmacol Biochem Behav"},{"key":"9959_CR42","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1073\/pnas.1423088112","volume":"112","author":"MP Kaster","year":"2015","unstructured":"Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, Baqi Y, Muller CE, Rodrigues AL, Porciuncula LO, Chen JF, Tome AR, Agostinho P, Canas PM, Cunha RA (2015) Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci U S A 112:7833\u20137838","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9959_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/BF00429665","volume":"85","author":"SK Kulkarni","year":"1985","unstructured":"Kulkarni SK, Mehta AK (1985) Purine nucleoside-mediated immobility in mice: reversal by antidepressants. Psychopharmacology 85:460\u2013463","journal-title":"Psychopharmacology"},{"issue":"Suppl 1","key":"9959_CR44","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.3233\/JAD-2010-1378","volume":"20","author":"DR Lara","year":"2010","unstructured":"Lara DR (2010) Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis 20(Suppl 1):S239\u2013S248","journal-title":"J Alzheimers Dis"},{"key":"9959_CR45","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1096\/fasebj.5.12.1916091","volume":"5","author":"J Linden","year":"1991","unstructured":"Linden J (1991) Structure and function of A1 adenosine receptors. FASEB J 5:2668\u20132676","journal-title":"FASEB J"},{"key":"9959_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0165-6147(91)90589-K","volume":"12","author":"J Linden","year":"1991","unstructured":"Linden J, Tucker AL, Lynch KR (1991) Molecular cloning of adenosine A1 and A2 receptors. Trends Pharmacol Sci 12:326\u2013328","journal-title":"Trends Pharmacol Sci"},{"key":"9959_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)12833-2","volume":"40","author":"LC Mahan","year":"1991","unstructured":"Mahan LC, McVittie LD, Smyk-Randall EM, Nakata H, Monsma FJ, Gerfen CR, Sibley DR (1991) Cloning and expression of an A1 adenosine receptor from rat brain. Mol Pharmacol 40:1\u20137","journal-title":"Mol Pharmacol"},{"key":"9959_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1037\/0735-7044.108.2.265","volume":"108","author":"TR Minor","year":"1994","unstructured":"Minor TR, Winslow JL, Chang WC (1994) Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats. Behav Neurosci 108:265\u2013276","journal-title":"Behav Neurosci"},{"key":"9959_CR49","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet 349:1498\u20131504","journal-title":"Lancet"},{"key":"9959_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","volume":"14","author":"DR Nelson","year":"2004","unstructured":"Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1\u201318","journal-title":"Pharmacogenetics"},{"key":"9959_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1523\/JNEUROSCI.21-02-00628.2001","volume":"21","author":"M Okada","year":"2001","unstructured":"Okada M, Nutt DJ, Murakami T, Zhu G, Kamata A, Kawata Y, Kaneko S (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J Neurosci 21:628\u2013640","journal-title":"J Neurosci"},{"key":"9959_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.ph.54.030192.001235","volume":"54","author":"ME Olah","year":"1992","unstructured":"Olah ME, Stiles GL (1992) Adenosine receptors. Annu Rev Physiol 54:211\u2013225","journal-title":"Annu Rev Physiol"},{"key":"9959_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7258(99)00051-0","volume":"85","author":"ME Olah","year":"2000","unstructured":"Olah ME, Stiles GL (2000) The role of receptor structure in determining adenosine receptor activity. Pharmacol Ther 85:55\u201375","journal-title":"Pharmacol Ther"},{"key":"9959_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","volume":"57","author":"R Ortiz","year":"2015","unstructured":"Ortiz R, Ulrich H, Zarate CA Jr, Machado-Vieira R (2015) Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog Neuro-Psychopharmacol Biol Psychiatry 57:117\u2013131","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9959_CR55","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","volume":"31","author":"CM Pariante","year":"2008","unstructured":"Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464\u2013468","journal-title":"Trends Neurosci"},{"key":"9959_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","volume":"49","author":"CM Pariante","year":"2001","unstructured":"Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391\u2013404","journal-title":"Biol Psychiatry"},{"key":"9959_CR57","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1517\/14656566.2014.903924","volume":"15","author":"S Perez-Lloret","year":"2014","unstructured":"Perez-Lloret S, Merello M (2014) Two new adenosine receptor antagonists for the treatment of Parkinson\u2019s disease: istradefylline versus tozadenant. Expert Opin Pharmacother 15:1097\u20131107","journal-title":"Expert Opin Pharmacother"},{"key":"9959_CR58","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00702-007-0714-8","volume":"114","author":"E Poleszak","year":"2007","unstructured":"Poleszak E (2007) Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm (Vienna) 114:1129\u20131134","journal-title":"J Neural Transm (Vienna)"},{"key":"9959_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11011-016-9810-5","volume":"31","author":"E Poleszak","year":"2016","unstructured":"Poleszak E, Stasiuk W, Szopa A, Wyska E, Serefko A, Oniszczuk A, Wo\u015bko S, \u015awi\u0105der K, Wla\u017a P (2016a) Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice. Metab Brain Dis 31:803\u2013814","journal-title":"Metab Brain Dis"},{"key":"9959_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharep.2015.06.138","volume":"68","author":"E Poleszak","year":"2016","unstructured":"Poleszak E, Szopa A, Wyska E, Kuku\u0142a-Koch W, Serefko A, Wo\u015bko S, Bogatko K, Wr\u00f3bel A, Wla\u017a P (2016b) Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice. Pharmacol Rep 68:56\u201361","journal-title":"Pharmacol Rep"},{"key":"9959_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lfs.2015.06.008","volume":"136","author":"E Poleszak","year":"2015","unstructured":"Poleszak E, Szopa A, Wyska E, Wo\u015bko S, Serefko A, Wla\u017a A, Pier\u00f3g M, Wr\u00f3bel A, Wla\u017a P (2015) The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. Life Sci 136:13\u201318","journal-title":"Life Sci"},{"key":"9959_CR62","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.pbb.2005.03.017","volume":"81","author":"E Poleszak","year":"2005","unstructured":"Poleszak E, Wla\u017a P, Szewczyk B, K\u0119dzierska E, Wyska E, Librowski T, Szymura-Oleksiak J, Fidecka S, Pilc A, Nowak G (2005) Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: behavioral and pharmacokinetic studies in mice. Pharmacol Biochem Behav 81:524\u2013529","journal-title":"Pharmacol Biochem Behav"},{"key":"9959_CR63","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00702-011-0630-9","volume":"118","author":"E Poleszak","year":"2011","unstructured":"Poleszak E, Wla\u017a P, Szewczyk B, Wla\u017a A, Kasperek R, Wr\u00f3bel A, Nowak G (2011) A complex interaction between glycine\/NMDA receptors and serotonergic\/noradrenergic antidepressants in the forced swim test in mice. J Neural Transm 118:1535\u20131546","journal-title":"J Neural Transm"},{"key":"9959_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.06.001","volume":"46","author":"E Poleszak","year":"2013","unstructured":"Poleszak E, Wo\u015bko S, Serefko A, Szopa A, Wla\u017a A, Szewczyk B, Nowak G, Wla\u017a P (2013) Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 46:29\u201335","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9959_CR65","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"9959_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1159\/000126788","volume":"60","author":"JM Reul","year":"1994","unstructured":"Reul JM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F (1994) Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60:509\u2013519","journal-title":"Neuroendocrinology"},{"key":"9959_CR67","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1210\/endo.133.1.8391426","volume":"133","author":"JM Reul","year":"1993","unstructured":"Reul JM, Stec I, Soder M, Holsboer F (1993) Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312\u2013320","journal-title":"Endocrinology"},{"key":"9959_CR68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","volume":"401","author":"DL Rosin","year":"1998","unstructured":"Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol 401:163\u2013186","journal-title":"J Comp Neurol"},{"key":"9959_CR69","first-page":"52","volume-title":"Anxiety disorders","author":"CL Ruby","year":"2011","unstructured":"Ruby CL, Adams CA, Mrowicka M, Choi DS (2011) Adenosine signaling in anxiety. In: Kalinin V (ed) Anxiety disorders. InTech, New Jersey, pp 52\u201368"},{"key":"9959_CR70","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000125264","volume":"50","author":"S Scaccianoce","year":"1989","unstructured":"Scaccianoce S, Navarra D, Di SA, Angelucci L, Endroczi E (1989) Adenosine and pituitary-adrenocortical axis activity in the rat. Neuroendocrinology 50:464\u2013468","journal-title":"Neuroendocrinology"},{"key":"9959_CR71","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-4159.1991.tb08257.x","volume":"57","author":"SN Schiffmann","year":"1991","unstructured":"Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991a) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57:1062\u20131067","journal-title":"J Neurochem"},{"key":"9959_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0304-3940(91)90391-6","volume":"130","author":"SN Schiffmann","year":"1991","unstructured":"Schiffmann SN, Libert F, Vassart G, Vanderhaeghen JJ (1991b) Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett 130:177\u2013181","journal-title":"Neurosci Lett"},{"key":"9959_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0301-0082(95)00035-6","volume":"48","author":"AM Sebasti\u00e3o","year":"1996","unstructured":"Sebasti\u00e3o AM, Ribeiro JA (1996) Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol 48:167\u2013189","journal-title":"Prog Neurobiol"},{"key":"9959_CR74","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","volume":"193","author":"AM Sebasti\u00e3o","year":"2009","unstructured":"Sebasti\u00e3o AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Handb Exp Pharmacol 193:471\u2013534","journal-title":"Handb Exp Pharmacol"},{"key":"9959_CR75","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"9959_CR76","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E","volume":"27","author":"P Svenningsson","year":"1997","unstructured":"Svenningsson P, Hall H, Sedvall G, Fredholm BB (1997a) Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 27:322\u2013335","journal-title":"Synapse"},{"key":"9959_CR77","doi-asserted-by":"crossref","unstructured":"Svenningsson P, Le Moine C, Kull B, Sunahara R, Bloch B, Fredholm BB (1997b) Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80:1171\u20131185","DOI":"10.1016\/S0306-4522(97)00180-2"},{"key":"9959_CR78","unstructured":"Szewczyk B, Bra\u0144ski P, Wiero\u0144ska JM, Pa\u0142ucha A, Pilc A, Nowak G (2002) Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol 54:681\u2013685"},{"key":"9959_CR79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pnpbp.2008.12.011","volume":"33","author":"B Szewczyk","year":"2009","unstructured":"Szewczyk B, Poleszak E, Wla\u017a P, Wr\u00f3bel A, Blicharska E, Cichy A, Dyba\u0142a M, Siwek A, Pomierny-Chamio\u0142o L, Piotrowska A, Bra\u0144ski P, Pilc A, Nowak G (2009) The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuro-Psychopharmacol Biol Psychiatry 33:323\u2013329","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9959_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.taap.2017.10.020","volume":"337","author":"A Szopa","year":"2017","unstructured":"Szopa A, Doboszewska U, Herbet M, Wo\u015bko S, Wyska E, \u015awi\u0105der K, Serefko A, Korga A, Wla\u017a A, Wr\u00f3bel A, Ostrowska M, Terlecka J, Kanadys A, Poleszak E, Dudka J, Wla\u017a P (2017) Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of ve serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression. Toxicol Appl Pharmacol 337:95\u2013103","journal-title":"Toxicol Appl Pharmacol"},{"key":"9959_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00210-015-1189-z","volume":"389","author":"A Szopa","year":"2016","unstructured":"Szopa A, Poleszak E, Wyska E, Serefko A, Wo\u015bko S, Wla\u017a A, Pier\u00f3g M, Wr\u00f3bel A, Wla\u017a P (2016) Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn Schmiedebergs Arch Pharmacol 389:211\u2013221","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9959_CR82","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","volume":"17","author":"L Tondo","year":"2003","unstructured":"Tondo L, Isacsson G, Baldessarini R (2003) Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 17:491\u2013511","journal-title":"CNS Drugs"},{"key":"9959_CR83","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1734-1140(13)71505-6","volume":"65","author":"J Vetulani","year":"2013","unstructured":"Vetulani J (2013) Early maternal separation: a rodent model of depression and a prevailing human condition. Pharmacol Rep 65:1451\u20131461","journal-title":"Pharmacol Rep"},{"key":"9959_CR84","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/B978-0-12-801022-8.00015-5","volume":"119","author":"K Yamada","year":"2014","unstructured":"Yamada K, Kobayashi M, Kanda T (2014) Involvement of adenosine A2A receptors in depression and anxiety. Int Rev Neurobiol 119:373\u2013393","journal-title":"Int Rev Neurobiol"},{"key":"9959_CR85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pbb.2013.10.022","volume":"114-115","author":"K Yamada","year":"2013","unstructured":"Yamada K, Kobayashi M, Mori A, Jenner P, Kanda T (2013) Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents. Pharmacol Biochem Behav 114-115:23\u201330","journal-title":"Pharmacol Biochem Behav"},{"key":"9959_CR86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0304-3940(02)00828-5","volume":"332","author":"T Yamato","year":"2002","unstructured":"Yamato T, Yamasaki S, Misumi Y, Kino M, Obata T, Aomine M (2002) Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine levels in rat. Neurosci Lett 332:87\u201390","journal-title":"Neurosci Lett"},{"key":"9959_CR87","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00210-007-0135-0","volume":"375","author":"M Yang","year":"2007","unstructured":"Yang M, Soohoo D, Soelaiman S, Kalla R, Zablocki J, Chu N, Leung K, Yao L, Diamond I, Belardinelli L, Shryock JC (2007) Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists. Naunyn Schmiedeberg's Arch Pharmacol 375:133\u2013144","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"9959_CR88","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","volume":"392","author":"UM Zanger","year":"2008","unstructured":"Zanger UM, Turpeinen M, Klein K, Schwab M (2008) Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem 392:1093\u20131108","journal-title":"Anal Bioanal Chem"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-018-9959-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9959-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9959-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T20:55:40Z","timestamp":1755723340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-018-9959-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9959"],"URL":"https:\/\/doi.org\/10.1007\/s12640-018-9959-2","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All procedures performed in studies involving animals were in accordance with the European Communities Council Directive of 22 September 2010 (2010\/63\/EU) and Polish legislation acts concerning animal experimentations. The experimental procedures and protocols were approved by the First Local Ethics Committee at the Medical University of Lublin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}